CSIMarket Company Name, Ticker, Industry, else..
 
Portage Biotech Inc   (NASDAQ: PRTG)
Other Ticker:  
 
 
Price: $8.3900 $0.90 12.016%
Day's High: $8.6 Week Perf: -2.33 %
Day's Low: $ 7.00 30 Day Perf: 99.67 %
Volume (M): 298 52 Wk High: $ 216.00
Volume (M$): $ 2,437 52 Wk Avg: $34.48
Open: $7.92 52 Wk Low: $2.81



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 0
 Employees 11
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -75
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 0

Portage Biotech Inc
Portage Biotech Inc. is a biopharmaceutical company that specializes in the development of innovative therapeutics for various medical conditions. They focus on identifying promising early-stage drug candidates and advancing them through the clinical development process. Portage Biotech aims to address unmet medical needs and improve patient outcomes by leveraging their expertise in drug discovery, drug development, and strategic partnerships. The company utilizes a portfolio approach to drug development, nurturing a pipeline of potential treatments across multiple therapeutic areas. Overall, Portage Biotech Inc. is dedicated to bringing forth innovative solutions to improve the lives of patients worldwide.


   Company Address: Clarence Thomas Building Tortola 0 CT
   Company Phone Number: 221.7378   Stock Exchange / Ticker: NASDAQ PRTG


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DCPH        0.08% 
REGN   -3.26%    
SUPN   -0.94%    
VRTX        3.97% 
YMAB   -6.73%    
ZYME        6.91% 
• View Complete Report
   



Shares

Portage Biotech Secures Critical Extension to Meet Stock Exchange Listing Requirements Amidst Compliance Challenges

Published Wed, Feb 12 2025 9:15 PM UTC

Portage Biotech Receives Extension to Achieve Stock Exchange ComplianceIn a significant development for Portage Biotech Inc. (NASDAQ: PTGE), the company announced that it has been granted an extension of time to meet the continued listing requirements set forth by the stock exchange. As of the writing of this article, the company s share price stands at $4.80. Understanding ...
Merger and Acquisition

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

Published Tue, Dec 17 2024 12:00 PM UTC

Portage Biotech?s Recent Developments: A Double-Edged Sword of Opportunity and Challenge OverviewPortage Biotech Inc. (NASDA...
Management Announcement

Portage Biotech Inc. Faces Declining Performance and Financial Losses, Expands Evaluation of Strategic Alternatives to Rebound in Healthcare Sector

Published Fri, Apr 12 2024 12:01 PM UTC

Portage Biotech Expands Strategic Alternatives Evaluation Amid Declining Performance and Financial Losses
Portage Biotech Inc., a leading biotechnology company, has announced its plans to expand the evaluation of strategic alternatives in a bid to improve its performance and financial standing. The company has recorded a decline in its share value by -4.65% in April 2024...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com